Rating History for Nautilus Biotechnology (NAUT) by Goldman Sachs

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/28/2025 Matthew Sykes Maintain Sell
(N/A)
1.00
(1.75)
 
 
  Details